C
Christophe Mariette
Researcher at university of lille
Publications - 261
Citations - 12305
Christophe Mariette is an academic researcher from university of lille. The author has contributed to research in topics: Esophagectomy & Esophageal cancer. The author has an hindex of 48, co-authored 258 publications receiving 10493 citations. Previous affiliations of Christophe Mariette include Lille University of Science and Technology & University of Lille Nord de France.
Papers
More filters
Journal ArticleDOI
Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102
Laurent Bedenne,Pierre Michel,Olivier Bouché,Chantal Milan,Christophe Mariette,Thierry Conroy,Denis Pezet,Bernard Roullet,Jean-François Seitz,Jean-Philippe Herr,Bernard Paillot,Patrick Arveux,Franck Bonnetain,Christine Binquet +13 more
TL;DR: It is suggested that, in patients with locally advanced thoracic esophageal cancers, especially epidermoid, who respond to chemoradiation, there is no benefit for the addition of surgery after cheMoradiation compared with the continuation of additional chemorADiation.
Journal ArticleDOI
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000–01 FFCD/SFRO study
Bruno Chauffert,F. Mornex,Franck Bonnetain,Ph. Rougier,Christophe Mariette,O. Bouche,J.-F. Bosset,Thomas Aparicio,Laurent Mineur,A. Azzedine,Pascal Hammel,J. Butel,N. Stremsdoerfer,Philippe Maingon,Laurent Bedenne +14 more
TL;DR: This intensive induction schedule of CHRT was more toxic and less effective than gemcitabine alone and was confirmed in a per-protocol analysis for patients who received 75% or more of the planned dose of radiotherapy.
Journal ArticleDOI
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.
Lionel Apetoh,François Ghiringhelli,Antoine Tesniere,Antoine Tesniere,Antoine Tesniere,Alfredo Criollo,Alfredo Criollo,Alfredo Criollo,Carla Ortiz,Carla Ortiz,Carla Ortiz,Rosette Lidereau,Christophe Mariette,Nathalie Chaput,Nathalie Chaput,Jean-Paul Mira,Suzette Delaloge,Fabrice Andre,Thomas Tursz,Guido Kroemer,Guido Kroemer,Guido Kroemer,Laurence Zitvogel +22 more
TL;DR: It is shown that the release of the high mobility group box 1 protein by dying tumor cells is mandatory to license host dendritic cells (DCs) to process and present tumor antigens, and this knowledge may be clinically exploited to predict the immunogenicity and hence the efficacy of chemotherapeutic regimens.
Journal ArticleDOI
Consensus Guidelines for Enhanced Recovery After Gastrectomy: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
Kim Erlend Mortensen,Magnus Nilsson,Karem Slim,Markus Schäfer,Christophe Mariette,Marco Braga,Franco Carli,Nicolas Demartines,S. M. Griffin,Kristoffer Lassen +9 more
TL;DR: Application of evidence‐based perioperative care protocols reduces complication rates, accelerates recovery and shortens hospital stay.
Journal ArticleDOI
Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
Christophe Mariette,Laetitia Dahan,F. Mornex,Emilie Maillard,Pascal-Alexandre Thomas,Bernard Meunier,Valérie Boige,Denis Pezet,William B. Robb,Valérie Le Brun-Ly,Jean-François Bosset,Jean-Yves Mabrut,Jean-Pierre Triboulet,Laurent Bedenne,Jean-François Seitz +14 more
TL;DR: Compared with surgery alone, NCRT with cisplatin plus fluorouracil does not improve R0 resection rate or survival but enhances postoperative mortality in patients with stage I or II EC.